Skip to main content

Animations

MJFF Publications

4351 - 4360 of 9134 Results
Title
Year
  • Year
  • 2024
  • 2024
  • 2024
  • 2018
  • 2020
  • 2022
  • 2022
  • 2024
  • 2025
  • 2024
  • Dual-task gait has prognostic value for cognitive decline in Parkinson’s disease
    2024
    Summary Details
    RESTRICTED
    Title: Dual-task gait has prognostic value for cognitive decline in Parkinson’s disease
    Journal Name: Journal of Clinical Neuroscience
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.jocn.2024.06.006
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Parkinson's disease: Still waiting for a cure
    Journal Name: Clinical and Translational Science
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1111/cts.13898
    Citation Count: 1
  • Summary Details
    OPEN
    Title: A genetic and proteomic comparison of key AD biomarkers across tissues
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/alz.14139
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Estimating the Evolution of Disease in the Parkinson’s Progression Markers Initiative
    Journal Name: Neurodegenerative Diseases
    Publisher: S. Karger AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1159/000488780
    Citation Count: 26
  • Summary Details
    OPEN
    Title: New 2013 incidence peak in childhood narcolepsy: more than vaccination?
    Journal Name: Sleep
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/sleep/zsaa172
    Citation Count: 22
  • Exploration of Protein Aggregations in Parkinson’s Disease Through Computational Approaches and Big Data Analytics
    2022
    Summary Details
    RESTRICTED
    Title: Exploration of Protein Aggregations in Parkinson’s Disease Through Computational Approaches and Big Data Analytics
    Journal Name: Methods in Molecular Biology
    Publisher: Springer US
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/978-1-0716-1546-1_19
    Citation Count: 3
  • Characterization of Axon Guidance Phenotypes in Wnt/PCP Mutant Mice
    2022
    Summary Details
    RESTRICTED
    Title: Characterization of Axon Guidance Phenotypes in Wnt/PCP Mutant Mice
    Journal Name: Methods in Molecular Biology
    Publisher: Springer US
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/978-1-0716-2035-9_17
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Interaction of PINK1 with nucleotides and kinetin
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1126/sciadv.adj7408
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Sample size estimates for biomarker-based outcome measures in clinical trials in autosomal dominant Alzheimer's disease
    Journal Name: The Journal of Prevention of Alzheimer's Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.tjpad.2025.100133
    Citation Count: 2
  • Summary Details
    OPEN
    Title: A structural pathway for class III PI 3-kinase activation by the myristoylated GTP-binding pseudokinase VPS15
    Journal Name: Biophysical Journal
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.bpj.2023.11.384
    Citation Count: 2
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.